Business and FinanceBusiness and Finance
Sat, March 8, 2025
[ Yesterday Evening ] - BBC
Israel-Gaza war
[ Yesterday Evening ] - BBC
Pulse win inaugural Netball Super Cup
[ Yesterday Afternoon ] - WNEM
STEM Workshop brings learning to life
[ Yesterday Afternoon ] - CNBC
The Look Ahead: March 7, 2025
[ Yesterday Afternoon ] - Wired
What's Driving Tesla's Woes?
[ Yesterday Morning ] - NBA
E. STANLEY KROENKE
[ Yesterday Morning ] - MSN
S. Korean actress Moon Jung-hee

1:10 Stock Split of Pharma Stock: Record Date Set For March 21; What Investors Should Do Next?


Published on 2025-03-08 04:01:14 - Goodreturns
  Print publication without navigation

  • On Friday, the shares of Shukra Pharmaceuticals ended 1.99% lower at Rs 236.40 per share on the BSE with a market cap of Rs 1,035.15 Cr after the company declared record date for 1:10 stock split.

The article from Goodreturns discusses the upcoming 1:10 stock split for a pharmaceutical company, with the record date set for March 21. This stock split will increase the number of shares each investor holds by a factor of ten, effectively reducing the price per share to make the stock more accessible to small investors. The article advises investors to consider several factors before deciding their next steps: understanding the implications of the stock split, reviewing the company's fundamentals, and assessing market conditions. It suggests that while a stock split itself does not add intrinsic value to the company, it often leads to increased liquidity and can potentially attract more investors, possibly driving up the stock price in the short term. Investors are encouraged to evaluate their investment strategy, whether to hold, buy more, or sell, based on their financial goals and the company's future prospects.

Read the Full Goodreturns Article at:
[ https://www.goodreturns.in/personal-finance/investment/1-10-stock-split-of-pharma-stock-record-date-set-for-march-21-what-investors-should-do-next-1410713.html ]